Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Nutritional therapy with omega-3 for lung cancer surgery patients

Official title: Effect of Perioperative Nutrition Enriched With Omega-3 on the Incidence of Infections in Oncologic Patients Following Lung Resection

Run by National Institute of Respiratory Diseases, Mexico · NCT06531460 · Data updated 2026-11-12

This study is testing if giving lung cancer surgery patients an omega-3 enriched nutritional formula can help reduce infections and improve recovery after their surgery.

More Lung Cancer trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment310 (estimated)
SponsorNational Institute of Respiratory Diseases, Mexico
Government
Locations1 site (Mexico City)
StatusRecruiting
StartedJuly 25, 2024
Main results expectedDecember 2026
Study endsJuly 2027
Registry record updatedAugust 1, 2024
Trial IDNCT06531460 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include lung cancer patients scheduled for elective lung resection surgery who can provide informed consent.

Probably not a fit

Patients with acute or chronic organ failure, fish allergies, recent surgeries, or those who are immunocompromised may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of an omega-3 enriched nutritional formula on the incidence of infections and inflammatory responses in lung cancer patients undergoing lung resection surgery. Participants will receive either fish oil enteral supplementation, fish oil oral supplementation, or standard nutritional support without fish oil. The goal is to determine if omega-3 can improve postoperative outcomes within 30 days following surgery. The study aims to enhance prehabilitation nutrition strategies for better recovery in this patient population.

Why it matters

Potential benefit: If successful, this approach could reduce postoperative infections and improve recovery outcomes for lung cancer patients undergoing surgery.

How similar studies have gone: While the specific combination of omega-3 and lung resection is novel, previous studies have shown potential benefits of omega-3 in improving surgical outcomes in various patient populations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Lung cancer diagnosis
* Elective surgery for lung resection schedule at least four days before surgery
* Signed informed consent.

Exclusion Criteria:

* Acute or chronic organ failure as hepatic or renal insufficiency
* Patients with fish-allergy
* History of any surgery within 3 months
* Immunocompromised patients

Where it's running

  • National Institute of Respiratory Diseases
    Mexico City, Mexico
    Recruiting

Study contacts

  • Principal investigator: Ivan A Osuna-Padilla, PhD — Instituto Nacional de Enfermedades Respiratorias
  • Study coordinator: Ivan A Osuna-Padilla, PhD
  • Email: ivan.osuna@iner.gob.mx
  • Phone: 5487-1700

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.